Ketamine: New Use for an Old Hat
Khidr Hassan, S El-Mallakh Rif
Journal of Clinical Anesthesia and Pain Management September 22, 2017 DOI: 10.36959/377/320 (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Esketamine Ketamine |
| Key points | Depression ranks third for global disease burden according to the WHO and is estimated to affect 350 million people worldwide. Its economic burden is estimated to have grown 21.5% from 2005 to 2010, from $173.2 billion to $210.5 billion. |
Abstract
Depression is one of the leading causes of disability not only in the US but worldwide as well. It is ranked third for global disease burden by the WHO and estimated to affect 350 million people worldwide. The economic burden of depression is estimated to have increased by 21.5% from 2005 to 2010 (from $173.2 billion to $210.5 billion).